My Locations
Gary C. Werths Building at Siteman Cancer Center
Siteman Cancer Center at Barnes-Jewish West County Hospital
Expertise & Training
Julie Margenthaler, MD, FACS
2 minsWashington University surgeon Julie Margenthaler, MD, FACS, discusses what breast cancer patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Margenthaler: https://siteman.wustl.edu/doctor/margenthaler-julie/
Learn more about the Siteman Approach to Breast Cancer: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/our-approach/
Learn more about all breast cancer treatment options at Siteman Cancer Center: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/treatments/
Hear from Siteman patients who discuss their journey with breast cancer diagnosis, treatment and recovery: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/patient-stories/
Clinical Expertise
As a member of our breast cancer specialist team, Dr. Margenthaler cares for patients diagnosed with breast cancer through treatment and recovery. Learn more about how Dr. Margenthaler and Siteman approach breast cancer diagnosis and staging, treatment and recovery.
Primary Academic Title
Professor of Surgery, Division of General Surgery, Section of Endocrine and Oncologic Surgery, WashU Medicine
Board Certification
- 2006: American Board of Surgery, General Surgery
Training
- 1997 - 1999: Resident, General Surgery, Saint Louis University, St. Louis, MO
- 1999 - 2002: Research Fellow, WashU Medicine, St. Louis, MO
- 2002 - 2005: Resident, General Surgery, WashU Medicine, St. Louis, MO
- 2005 - 2006: Fellow, Surgical Oncology, WashU Medicine, St. Louis, MO
Education
- 1997: MD, Southern Illinois University, Springfield, IL
Research & Selected Publications
Research Interest
Identification of minimally invasive approaches to breast cancer staging using imaging combined with molecular techniques; the identification of non-BRCA genes responsible for the development of breast cancer in young women under the age of 40; and the design of novel gene-specific approaches to breast cancer treatment.
Research Publications